-
- TRL (Technology readiness level) -
-
- Titre Modified-release 3D printed capsules
- Description The invention describes the production of functionalized capsules by 3D printing to modify the release of drugs. It proposes to substitute the commonly used dipping method of coating in compounding pharmacies, hospital and preclinical studies by a 3D printing method of production as the efficacy of such coating method is known to be erratic and may lead to potential therapeutic failure.
The invention relates to 3D printing techniques which represents an elegant tool for designing simple, accurate, cheap, structured and tailored drug delivery systems in pharmaceutics. Here, 3D printing is used to produce unique modified-release (e.g. enteric, colonic, sustained release) capsules ready-to-use.
- Bénéfices More robust process – less erratic in term of efficacy
One-step process
Automatic process
No use of organic solvents
Ability to prepare magistral preparations as well as small batches for pre-clinical studies with sustained-release properties
- Nouveauté New method for the production of functionalized capsules by 3D printing used to modify the release of drugs.
- Mots clés 3D printing, Caps, Delivery systems
- Secteurs Chemicals, Materials & plant-based materials Health
